Skip to content
Research Article Open access CC BY 3.0

High Membrane Cholesterol in CLL B-Cells and Differential Expression of Cholesterol Synthesis Genes in IG GENE-Unmutated vs Mutated Cells

Cécile Tomowiak, Anne Kennel, Hélène Gary-Gouy, Nader Hadife, Pierre Feugier, Torsten Haferlach, Marie C Béné, Ali Dalloul

Journal of Advances in Medicine and Medical Research · pp. 313–326 · Published 28 Mar 2012

10.9734/BJMMR/2012/944

Abstract

Objectives: Chronic lymphocytic leukaemia (CLL) is associated with abnormalities of the B-Cell Receptor (BCR) signalling, including low responsiveness to antigenic stimulation and constitutive phosphorylation of several components of the signalling pathway. In B-cells, BCR-mediated signalling is regulated in part by the amount of membrane cholesterol. It was observed that Statins, pharmacological inhibitors of cholesterol synthesis, induce apoptosis of CLL cells in vitro and in vivo. Having previously reported that ectopic expression of CD5 in a B-cell line stimulated the transcription of genes involved in the synthesis of cholesterol, we investigated the expression and synthesis of cholesterol in CLL B-cells. Study Design & Methodology: Plasma membrane cholesterol in CLL cells was evaluated by staining with Filipin and Flow cytometry in 26 patients. CLL cells were cultured with Lovastatin and subG1 cells and Gumprecht’s shadows counted thereafter; surface expression of IgM, CD19 and CD5 was analysed. The expression of cholesterol synthesis genes was investigated in transcriptomic data from the MILE project (150 CLL and 110 controls). Results: We confirmed that leukemic B-cells contained more cholesterol in their plasma membranes than their normal counterparts. An enhanced expression of genes involved in the synthesis of cholesterol in CLL as compared to healthy controls was observed. Interestingly, among the 150 CLL patients analyzed, four cholesterol synthesis genes were activated in 65 “Ig-mutated” (M) in comparison to 69 “Ig-unmutated” (UM) CLLs. Leukemic cells cultured with Lovastatin exhibited a dose-response apoptosis, however surface IgM expression was unaffected and CD19 and CD5 were downregulated at highest concentrations only. Conclusions: High membrane cholesterol in CLL cells may explain their sensitivity to Statins, with a potential difference between UM- and M-CLL.

Chronic lymphocytic leukaemia cholesterol apoptosis statins

References (38)

  1. 1 Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia [DOI]
  2. 2 Predominant Autoantibody Production by Early Human B Cell Precursors [DOI]
  3. 3 Chronic Lymphocytic Leukemia [DOI]
  4. 4 Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia [DOI]
  5. 5 Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells [DOI]
  6. 6 The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
  7. 7 Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group [DOI]
  8. 8 Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells [DOI]
  9. 9 The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire [DOI]
  10. 10 Chronic lymphocytic leukemia: revelations from the B-cell receptor [DOI]
  11. 11 Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity [DOI]
  12. 12 Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia [DOI]
  13. 13 B-cell tolerance checkpoints in health and autoimmunity [DOI]
  14. 14 Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging [DOI]
  15. 15 A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies [DOI]
  16. 16 Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production [DOI]
  17. 17 Chronic Lymphocytic Leukemia [DOI]
  18. 18 Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial [DOI]
  19. 19 Lipid rafts and B-cell activation [DOI]
  20. 20 Cd5 Maintains Tolerance in Anergic B Cells [DOI]
  21. 21 Lipid rafts and B cell signaling [DOI]
  22. 22 Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9 [DOI]
  23. 23 Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-κB in B cell clonal anergy [DOI]
  24. 24 Natural Phosphorylation of CD5 in Chronic Lymphocytic Leukemia B Cells and Analysis of CD5-Regulated Genes in a B Cell Line Suggest a Role for CD5 in Malignant Phenotype [DOI]
  25. 25 Material Properties of Lipid Microdomains: Force-Volume Imaging Study of the Effect of Cholesterol on Lipid Microdomain Rigidity [DOI]
  26. 26 Evaluation of the polyene antibiotic filipin as a cytochemical probe for membrane cholesterol. [DOI]
  27. 27 Antigen-Stimulated Dissociation of BCR mIg from Ig-α/Ig-β [DOI]
  28. 28 Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells [DOI]
  29. 29 Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx [DOI]
  30. 30 Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity inVH4-34 expressing single leukemic B cells [DOI]
  31. 31 Simvastatin impairs mitogen‐induced proliferation of malignant B‐lymphocytes from humans—in vitro and in vivo studies [DOI]
  32. 32 Filipin as a flow microfluorometry probe for cellular cholesterol [DOI]
  33. 33 HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway [DOI]
  34. 34 Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells [DOI]
  35. 35 The ultrastructural localization of immunoglobulin in chronic lymphocytic lymphoma cells: changes in light and heavy chain distribution induced by mitogen stimulation [DOI]
  36. 36 The ras/cholesterol connection: implications for ras oncogenicity.
  37. 37 Intracellular immunoglobulin in lymphocytes from patients with chronic lymphocytic leukemia: An immunoelectron microscopic study [DOI]
  38. 38 Entstehung und Bedeutung der Gumprecht'schen Kernschatten bei chronisch lymphatischer Leukämie [DOI]

Cited by 4

Post-lanosterol biosynthesis of cholesterol and cancer

Miguel A Lasunción, Covadonga Martín-Sánchez, Alberto Canfrán-Duque · Current Opinion in Pharmacology · 2012

Showing 1 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

53

Page views

0

PDF downloads

10

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.